Prognostic Value of Microvascular Resistance at Rest in Patients With Takotsubo Syndrome
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Microvascular resistance (MR) is increased in takotsubo syndrome (TTS) and can be assessed by a validated pressure-wire-free tool called nonhyperemic angiography-derived index of microcirculatory resistance (NH-IMRangio).
OBJECTIVES: The authors aimed to study whether the degree and extent of an altered MR in TTS patients were associated with 1-year prognosis.
METHODS: The authors recruited 181 consecutive patients with TTS who underwent cardiac angiography. Impaired MR was defined as an NH-IMRangio ≥25. The degree and extent of impaired MR were assessed by the value of maximum NH-IMRangio in each major coronary artery and by the number of coronary arteries with an NH-IMRangio ≥25, respectively. Major adverse cardiac events (MACE) were a composite of cardiovascular death, heart failure event, acute myocardial infarction, and hospitalization for symptomatic arrhythmias.
RESULTS: A total of 166 patients had NH-IMRangio available. The mean age was 74.8 years, and 83% were women. The rate of MACE at 1 year was 21.1%, mainly due to heart failure events that were generally mild. Kaplan-Meier curves showed higher rates of MACE in patients with higher NH-IMRangio (28.9% vs 13.3%; P = 0.019) and in those with 3 coronary arteries with increased MR compared to those with 2 or 1 affected arteries (33.3% vs 15.9% vs 9.5%; P = 0.040 and P = 0.040, respectively). After a multivariable Cox regression analysis, higher values of NH-IMRangio (HR: 3.41 [95% CI: 1.54-7.52]; P = 0.002) and the presence of 3 coronary arteries with increased MR (HR: 6.39 [95% CI: 1.46-27.87]; P = 0.014) were independent predictors of MACE in TTS patients.
CONCLUSIONS: The degree and extent of an impaired MR assessed by a validated pressure-wire-free tool were independent predictors of MACE at 1-year follow-up in TTS patients.
Errataetall: |
CommentIn: JACC Cardiovasc Imaging. 2022 Oct;15(10):1796-1798. - PMID 36202459 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
JACC. Cardiovascular imaging - 15(2022), 10 vom: 01. Okt., Seite 1784-1795 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sans-Roselló, Jordi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Coronary microvascular dysfunction (CMD) |
---|
Anmerkungen: |
Date Completed 28.09.2022 Date Revised 03.11.2022 published: Print-Electronic CommentIn: JACC Cardiovasc Imaging. 2022 Oct;15(10):1796-1798. - PMID 36202459 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jcmg.2022.03.030 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM346423597 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM346423597 | ||
003 | DE-627 | ||
005 | 20231226031423.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jcmg.2022.03.030 |2 doi | |
028 | 5 | 2 | |a pubmed24n1154.xml |
035 | |a (DE-627)NLM346423597 | ||
035 | |a (NLM)36125887 | ||
035 | |a (PII)S1936-878X(22)00234-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sans-Roselló, Jordi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prognostic Value of Microvascular Resistance at Rest in Patients With Takotsubo Syndrome |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.09.2022 | ||
500 | |a Date Revised 03.11.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: JACC Cardiovasc Imaging. 2022 Oct;15(10):1796-1798. - PMID 36202459 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: Microvascular resistance (MR) is increased in takotsubo syndrome (TTS) and can be assessed by a validated pressure-wire-free tool called nonhyperemic angiography-derived index of microcirculatory resistance (NH-IMRangio) | ||
520 | |a OBJECTIVES: The authors aimed to study whether the degree and extent of an altered MR in TTS patients were associated with 1-year prognosis | ||
520 | |a METHODS: The authors recruited 181 consecutive patients with TTS who underwent cardiac angiography. Impaired MR was defined as an NH-IMRangio ≥25. The degree and extent of impaired MR were assessed by the value of maximum NH-IMRangio in each major coronary artery and by the number of coronary arteries with an NH-IMRangio ≥25, respectively. Major adverse cardiac events (MACE) were a composite of cardiovascular death, heart failure event, acute myocardial infarction, and hospitalization for symptomatic arrhythmias | ||
520 | |a RESULTS: A total of 166 patients had NH-IMRangio available. The mean age was 74.8 years, and 83% were women. The rate of MACE at 1 year was 21.1%, mainly due to heart failure events that were generally mild. Kaplan-Meier curves showed higher rates of MACE in patients with higher NH-IMRangio (28.9% vs 13.3%; P = 0.019) and in those with 3 coronary arteries with increased MR compared to those with 2 or 1 affected arteries (33.3% vs 15.9% vs 9.5%; P = 0.040 and P = 0.040, respectively). After a multivariable Cox regression analysis, higher values of NH-IMRangio (HR: 3.41 [95% CI: 1.54-7.52]; P = 0.002) and the presence of 3 coronary arteries with increased MR (HR: 6.39 [95% CI: 1.46-27.87]; P = 0.014) were independent predictors of MACE in TTS patients | ||
520 | |a CONCLUSIONS: The degree and extent of an impaired MR assessed by a validated pressure-wire-free tool were independent predictors of MACE at 1-year follow-up in TTS patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a coronary microvascular dysfunction (CMD) | |
650 | 4 | |a nonhyperemic angiography-derived index of microcirculatory resistance (NH-IMRangio) | |
650 | 4 | |a takotsubo syndrome (TTS) | |
700 | 1 | |a Fernández-Peregrina, Estefanía |e verfasserin |4 aut | |
700 | 1 | |a Duran-Cambra, Albert |e verfasserin |4 aut | |
700 | 1 | |a Carreras-Mora, Jose |e verfasserin |4 aut | |
700 | 1 | |a Sionis, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Álvarez-García, Jesús |e verfasserin |4 aut | |
700 | 1 | |a García-García, Hector M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t JACC. Cardiovascular imaging |d 2008 |g 15(2022), 10 vom: 01. Okt., Seite 1784-1795 |w (DE-627)NLM186259573 |x 1876-7591 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2022 |g number:10 |g day:01 |g month:10 |g pages:1784-1795 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcmg.2022.03.030 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2022 |e 10 |b 01 |c 10 |h 1784-1795 |